Pressed Into Service Without Enough Thought: Small Firms In Germany Voice IP Fears Over EU MDR
Executive Summary
German medtech companies are keeping up the pressure for practical changes to be made to the EU Medical Device Regulation to limit its potentially damaging effects on product innovation and patient care, and drawing on recent support from German state economy ministers.
You may also be interested in...
German Ministers Call, Too, For Longer EU MDR/IVDR Transition – But Is It A Can Of Worms?
German ministers have joined those calling for a longer transition period for the EU's new MDR/IVDR. Is it time to heed those calls? Or is it time for the EU authorities to take greater responsibility for meeting current deadlines?
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.